These two authors contributed equally to the manuscript.
Clinical and Laboratory Investigations
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
Article first published online: 31 OCT 2013
© 2013 British Association of Dermatologists
British Journal of Dermatology
Volume 169, Issue 5, pages 1071–1080, November 2013
How to Cite
Kardaun, S.H., Sekula, P., Valeyrie-Allanore, L., Liss, Y., Chu, C.Y., Creamer, D., Sidoroff, A., Naldi, L., Mockenhaupt, M., Roujeau, J.C. and the RegiSCAR study group (2013), Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. British Journal of Dermatology, 169: 1071–1080. doi: 10.1111/bjd.12501
Funding source The RegiSCAR study was funded by grants from the European Commission (QLRT-2002-01738), GIS-Institut des Maladies Rares and INSERM (4CH09G) in France, and by a consortium of Pharmaceutical companies (Bayer Vital, Boehringer-Ingelheim, GlaxoSmithKline, MSD Sharp and Dohme, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, Wyeth).
Conflict of interest JC Roujeau was or is a member of the advisory board on drug safety for following companies. Boehringer-Ingelheim, Janssen, OM-Pharma, Menarini, Pfizer, Servier, Vertex. He was a consultant for Cephalon, Johnson & Johnson, Janssen, Medimune, Roche and Sanofi-Aventis. Role of the sponsors: The sponsors had no role in the design or conduct of the study, in the collection, analysis, and interpretation of data, or in the preparation, review, or approval of the manuscript.
- Issue published online: 31 OCT 2013
- Article first published online: 31 OCT 2013
- Accepted manuscript online: 16 JUL 2013 03:04AM EST
- Manuscript Accepted: 2 JUL 2013
- European Commission. Grant Number: QLRT-2002-01738
- GIS-Institut des Maladies Rares and INSERM. Grant Number: 4CH09G
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.